A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer.
Can ChenMinjun ChenYuju BaiYajun LiJie PengBiao YaoJiangping FengJian-Guo ZhouHu MaPublished in: Technology in cancer research & treatment (2024)
NCT05901584.